1233229-75-8
1233229-75-8
Chemical Structure
Bliretrigine
- CAS No.: 1233229-75-8
- Formula:C20H24N4O2
- Molecular Weight:352.43
IUPAC Name: (S)-2-(((1-ethyl-6-(p-tolyloxy)-1H-benzo[d]imidazol-2-yl)methyl)amino)propanamide
InChIKey: ZYUAASICHDTDEK-AWEZNQCLSA-N
SMILES: CCN1C2=CC(OC3=CC=C(C=C3)C)=CC=C2N=C1CN[C@@H](C)C(N)=O
Biological Activity: Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bliretrigine | 99.42% | Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
- [2]. Yoshihiro OYAMADA, et al. External medicinal preparation containing N2-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-yl]methyl}-L-alanineamide for treating and/or preventing peripheral neuropathic pain. Patent AU2019306705.
- [3]. Hironori Kinoshita, et al. Preparation of N2-[(benzimidazol-2-yl or imidazo[4,5-b]pyridin-2-yl)methyl]amino acid amide derivatives as inhibitors of sensory neuron specific sodium channel (SNS). Patent AU2009331179.
Keywords
